Tomohiro Matsuo

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Editorial Comment

Botulinum Toxin

Tyrosine Kinase

Lower Urinary Tract Symptoms

Top Venues

International journal of urology : official journal of the Japanese Urological Association

IJU case reports

Medicina (Kaunas, Lithuania)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Shintaro Mori, Tomohiro Matsuo, Hiroyuki Honda, Kyohei Araki, Kensuke Mitsunari, Kojiro Ohba, Yasushi Mochizuki, Ryoichi Imamura
Initial experience of enfortumab vedotin in a patient with metastatic urothelial carcinoma on hemodialysis: Two case reports. IJU case reports 7 (4) (2024)
Tomohiro Matsuo, Ryoichi Imamura
Editorial Comments on The harmful effects of overlooking acute bacterial prostatitis. International journal of urology : official journal of the Japanese Urological Association (2024)
Shintaro Mori, Tomohiro Matsuo, Hiroyuki Honda, Kyohei Araki, Kensuke Mitsunari, Kojiro Ohba, Yasushi Mochizuki, Ryoichi Imamura
Initial experience of enfortumab vedotin in a patient with metastatic urothelial carcinoma on hemodialysis: Two case reports. IJU case reports 7 (4) (2024)
Tomohiro Matsuo, Ryoichi Imamura
Editorial Comments on The harmful effects of overlooking acute bacterial prostatitis. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Tomohiro Matsuo, Ryoichi Imamura
Editorial Comments on The harmful effects of overlooking acute bacterial prostatitis. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Tomohiro Matsuo, Ryoichi Imamura
Editorial Comments on The harmful effects of overlooking acute bacterial prostatitis. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Yasufumi Ueda, Tomohiro Matsuo, Ken Kawada, Hidenori Ito, Kensuke Mitsunari, Kojiro Ohba, Ryoichi Imamura
The Relationship between the Presence of an Earlobe Crease and Overactive Bladder: A Cross-Sectional Case-Controlled Study. Medicina (Kaunas, Lithuania) 59 (3) (2023)
Shota Kakita, Tomohiro Matsuo, Masaharu Ohki, Ayaka Tsuchiyama, Takuji Yasuda, Hiromi Nakanishi, Kensuke Mitsunari, Kojiro Ohba, Ryoichi Imamura
Evans syndrome during pembrolizumab therapy for upper urinary tract cancer. IJU case reports 6 (5) (2023)
Tomohiro Matsuo, Ryoichi Imamura
Editorial Comments on Transvaginal ultrasonography for trigonitis diagnosis in women. International journal of urology : official journal of the Japanese Urological Association (2023)
Yasufumi Ueda, Tomohiro Matsuo, Ken Kawada, Hidenori Ito, Kensuke Mitsunari, Kojiro Ohba, Ryoichi Imamura
The Relationship between the Presence of an Earlobe Crease and Overactive Bladder: A Cross-Sectional Case-Controlled Study. Medicina (Kaunas, Lithuania) 59 (3) (2023)
Yasufumi Ueda, Tomohiro Matsuo, Ken Kawada, Hidenori Ito, Kensuke Mitsunari, Kojiro Ohba, Ryoichi Imamura
The Relationship between the Presence of an Earlobe Crease and Overactive Bladder: A Cross-Sectional Case-Controlled Study. Medicina (Kaunas, Lithuania) 59 (3) (2023)
Shota Kakita, Tomohiro Matsuo, Masaharu Ohki, Ayaka Tsuchiyama, Takuji Yasuda, Hiromi Nakanishi, Kensuke Mitsunari, Kojiro Ohba, Ryoichi Imamura
Evans syndrome during pembrolizumab therapy for upper urinary tract cancer. IJU case reports 6 (5) (2023)
Tomohiro Matsuo, Yasuyoshi Miyata, Hideki Sakai
Editorial Comment to Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial. International journal of urology : official journal of the Japanese Urological Association 29 (6) (2022)
Naoko Izumi, Tomohiro Matsuo, Yoshihisa Matsukawa
Associations among Physician-Patient Communication, Patient Satisfaction, and Clinical Effectiveness of Overactive Bladder Medication: A Survey of Patients with Overactive Bladder. Journal of clinical medicine 11 (14) (2022)
Tomohiro Matsuo, Hidenori Ito, Kensuke Mitsunari, Kojiro Ohba, Yasuyoshi Miyata
Relationship between Urinary Calcium Excretion and Lower Urinary Tract Symptoms. Metabolites 12 (3) (2022)
Tomohiro Matsuo, Yasuyoshi Miyata, Hideki Sakai
Editorial Comment from Dr Matsuo et al. to Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial. International journal of urology : official journal of the Japanese Urological Association 29 (5) (2022)
Yasuyoshi Miyata, Tomohiro Matsuo
Editorial Comment to Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre-enfortumab vedotin era. International journal of urology : official journal of the Japanese Urological Association 29 (7) (2022)
Kensuke Mitsunari, Yasuyoshi Miyata, Tomohiro Matsuo, Yuta Mukae, Asato Otsubo, Junki Harada, Tsubasa Kondo, Tsuyoshi Matsuda, Kojiro Ohba, Hideki Sakai
Pharmacological Effects and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia. Molecules (Basel, Switzerland) 26 (2) (2021)
Asato Otsubo, Tomohiro Matsuo, Yasuyoshi Miyata, Yuta Mukae, Kensuke Mitsunari, Kojiro Ohba, Hideki Sakai
Presurgical bladder wall thickness is a useful marker to predict the postsurgical improvement of symptoms in patients with pelvic organ prolapse-related overactive bladder. Lower urinary tract symptoms 13 (3) (2021)
Tomohiro Matsuo, Tatsufumi Nakamura, Katsuya Sato, Yasuyoshi Miyata, Hideki Sakai
Intravesical injection of onabotulinumtoxinA in neurogenic overactive bladder patients with human T-cell leukemia virus type 1-associated myelopathy: A single-institution case series. IJU case reports 4 (4) (2021)
Tsuyoshi Matsuda, Yasuyoshi Miyata, Yuichiro Nakamura, Asato Otsubo, Yuta Mukae, Junki Harada, Kensuke Mitsunari, Tomohiro Matsuo, Kojiro Ohba, Bungo Furusato, Hideki Sakai
Pathological significance and prognostic role of LATS2 in prostate cancer. The Prostate 81 (15) (2021)
Yasuyoshi Miyata, Tomohiro Matsuo, Kojiro Ohba, Kensuke Mitsunari, Yuta Mukae, Asato Otsubo, Junki Harada, Tsuyoshi Matsuda, Tsubasa Kondo, Hideki Sakai
Present Status, Limitations and Future Directions of Treatment Strategies Using Fucoidan-Based Therapies in Bladder Cancer. Cancers 12 (12) (2020)
Tsutomu Yuno, Yasuyoshi Miyata, Yuta Mukae, Asato Otsubo, Kensuke Mitsunari, Tomohiro Matsuo, Kojiro Ohba, Hideki Sakai
Mechanisms Underlying the Inhibition of Tyrosine Kinase Inhibitor-Induced Anorexia and Fatigue by Royal Jelly in Renal Cell Carcinoma Patients and the Correlation between Macrophage Colony Stimulating Factor and Inflammatory Mediators. Medical sciences (Basel, Switzerland) 8 (4) (2020)
Kyohei Araki, Yasuyoshi Miyata, Kojiro Ohba, Yuichiro Nakamura, Tomohiro Matsuo, Yasushi Mochizuki, Hideki Sakai
Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2. Medicines (Basel, Switzerland) 7 (11) (2020)
Yasuyoshi Miyata, Yuta Mukae, Junki Harada, Tsuyoshi Matsuda, Kensuke Mitsunari, Tomohiro Matsuo, Kojiro Ohba, Hideki Sakai
Pathological and Pharmacological Roles of Mitochondrial Reactive Oxygen Species in Malignant Neoplasms: Therapies Involving Chemical Compounds, Natural Products, and Photosensitizers. Molecules (Basel, Switzerland) 25 (22) (2020)